The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Jounce Therapeutics; Pfizer/EMD Serono; Sanofi
Speakers' Bureau - AstraZeneca; Dendreon; Genentech/Roche; Genomic Health; Merck; Sanofi
Research Funding - Janssen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
A randomized phase II study of atezolizumab plus recombinant human IL-7 (CYT107) or atezolizumab alone in patients with locally advanced or metastatic urothelial carcinoma (mUC): A Cancer Immunotherapy Trials Network Trial (CITN-14).
 
Evan Y. Yu
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Churchill Pharmaceuticals; Dendreon; EMD Serono; Incyte; Janssen; Merck; QED Therapeutics; Seagen; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen (Inst)
 
Steven Fling
No Relationships to Disclose
 
Bob Salim
No Relationships to Disclose
 
Randy F. Sweis
Honoraria - Bristol-Myers Squibb; Exelixis; Medscape
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Eisai; Exelixis; Puma Biotechnology
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Eisai (Inst); EpiVax Oncology (Inst); Genentech (Inst); Immunocore (Inst); Merck (Inst); Merck (Inst); Mirati Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Eisai; Exelixis
 
Gurkamal S. Chatta
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Rohit K. Jain
No Relationships to Disclose
 
Scott Edward Delacroix
No Relationships to Disclose
 
Helen Moon
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Prometheus
 
Andreanne Lacroix
No Relationships to Disclose
 
Judith C Kaiser
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Martin A. Cheever
No Relationships to Disclose
 
Russell Pachynski
No Relationships to Disclose